Skip to content

Companies Investors Funds People Markets

/

Loading company…

Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

© 2026 CapbaseData CC BY-NC 4.0 · Code AGPL-3.0support@capbase.fyi

Quince Therapeutics, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Q

Quince Therapeutics, Inc.

Private

Biotechnology

SEC CIK: 0001662774

Founded: —Source: [SEC]
Headquarters: South San Francisco, CALIFORNIASource: [SEC]
Country: United StatesSource: [SEC]
Headcount: 0Source: [SEC]
Stage

Sign inTotal raised

UndisclosedSource: [SEC]Last valuation

Overview

Funding rounds

3 rounds

3 rounds · latest Private placement (Form D), May 2026

Sign in to see 3 rounds.

Investors

3 on file

Sign in to see 3 investors.

People

Leadership

Dirk ThyeExecutive OfficerSince 2026Source: [SEC]Source: [SEC]

Brigette RobertsExecutive OfficerSince 2026Source: [SEC][SEC]

Acquisitions

Quince Therapeutics, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Diversity investments

No diversity signals recorded yet for Quince Therapeutics, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Series A

Sector

Healthcare

Operating status

Source:

Sign in to see 5 more people.